Alpha DNA Investment Management’s Pentair PNR Stock Holding History
Bought
Maintained
Sold
Other funds holding PNR
PAMU
Alpha DNA Investment Management's PNR Position: Q2 2021 in Review
Alpha DNA Investment Management sold out of Pentair (PNR) in Q2 2021, closing a stake of 48 shares — an estimated $2K sold.
Alpha DNA Investment Management first reported a position in PNR in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 518 funds tracked by Wall St. Rank hold PNR as of Q2 2021.
- Alpha DNA Investment Management reported no remaining Pentair position as of Q2 2021 after selling out during the quarter.
- Alpha DNA Investment Management sold 48 Pentair shares in Q2 2021, an estimated $2K.
- Alpha DNA Investment Management first reported a position in Pentair in Q1 2021 and held it in 1 quarter.
- Alpha DNA Investment Management's Pentair position peaked at $2K in Q1 2021.
- 518 funds tracked by Wall St. Rank held Pentair as of Q2 2021.
Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.